Efficacy and Safety of Pembrolizumab in Patients with Refractory Advanced Biliary Tract Cancer: Tumor Proportion Score as a Potential Biomarker for Response

Junho Kang, Changhoon Yoo, Hee-Sang Hwang et al.|Cancer Research and Treatment|2019

Cited by 71